Vedolizumab (anti-α4β7-integrin), 1mg*25

Vedolizumab (anti-α4β7-integrin), 1mg*25

Risankizumab (anti-IL-23), 1mg*5

Risankizumab (anti-IL-23), 1mg*5

Risankizumab (anti-IL-23), 1mg

2.143,19 RON
SKU
SKM_A2046_1mg

Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.

Mai multe informatii
Price 1.801,00 RON (preturile sunt fara TVA)
Description

Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.